7 top-performing Dutch venture capital funds by IRR
In this blog post, we’re looking more closely at high-performing VC funds in the Netherlands. In particular, we are highlighting the top VC funds across the country by IRR, or Internal Rate of Return, as of September 9, 2021.
Note that clicking on any fund or company name in the list below will take you to a PitchBook profile preview. Our profile previews provide a cursory sense of the types of robust data PitchBook clients can access with their subscription.
Top 7 Dutch VC funds by IRR*
*According to PitchBook data as of September 8, 2021; data is subject to change frequently
BioGeneration Ventures II
- IRR: 104%
- Vintage: 2012
- Fund size: €15M
- Close date: December 2012
Based in Naarden, Netherlands and led by Founder and Managing Partner Edward van Wezel, BioGeneration Ventures II is a venture capital fund that makes investments into healthcare companies across seed, early- and late-stages. The fully invested fund has committed capital to Maastricht’s Cristal Therapeutics and Oss-based Synaffix, both drug discovery startups, among other companies.
Acrobator Angel Fund
- IRR: 88%
- Vintage: 2011
- Fund size: €2.4M
- Close date: January 2019
Amsterdam-based VC firm Acrobator Ventures runs the Acrobator Angel Fund, which tends to make seed- and early-stage investments in information technology startups. The fund team consists of Co-founder and General Partner Bas Godska and Co-founder and Managing Partner Joachim Laqueur. Recent investments have included Berlin-based financial software Monite, Singaporean time-tracking app Clockster, and the Bay Area’s collaborative AI platform Omdena.
FORBION Capital Fund IV
- IRR: 71.28%
- Vintage: 2018
- Fund size: €360M
- Close date: September 2018
Headquartered in Naarden, FORBION is a VC firm that works closely with entrepreneurs to build life sciences companies with technologies and products designed to transform peoples’ lives. FORBION IV focuses on healthcare opportunities in the EU and UK, as well as in North America. The fund has eight active investments, including the Naarden-based drug discovery startup Azafaros, German biopharmaceutical company Catalym and Montreal’s drug developer Inversago, among others.
FORBION Capital Fund III
- IRR: 44.04%
- Vintage: 2015
- Fund size: €183M
- Close date: April 2016
A member of the FORBION fund family, FORBION III provides capital to early-stage VC healthcare startups, and particularly in drug-, device- and diagnostics companies. Around 70% of the fund will be aimed at Europe, with the remainder set to be allocated across the United States and Canada. A few of FORBION III’s active investments include Brighton, UK-based Enterprise Therapeutics, Nijmegen’s Escalier Biosciences and Amsterdam’s NorthSea Therapeutics.
Newion Investments II
- IRR: 33%
- Vintage: 2011
- Fund size: €48M
- Close date: April 2011
Amsterdam’s Newion Investments II is a venture capital fund whose fund strategy includes investing primarily in early- and later-stage information technology startups. Of the fund’s eight active investments, the most recent include social advertising platform The Next Ad and employee-management software L1NDA—both based in Amsterdam. The Luxembourg-based European Investment Fund, a fund of funds, is a limited partner on Newion Investments II.
FCF I Co-Invest Fund I
- IRR: 30.77%
- Vintage: 2009
- Fund size: €54M
- Close date: September 2010
Another fund managed by FORBION, FCF I Co-Invest Fund I is a fully invested co-investment general fund led by Operating Partner Sander van Deventer. In addition to FORBION, Oslo, Norway-based insurance company Kommunal Landspensjonskasse is a limited partner on FCF I, which distributed capital evenly across early- and later-stage VC healthcare companies. The fund has two former investments—Suffolk, UK-based drug discovery company Xention and Rhein Biotech, a biotech company headquartered in Düsseldorf, Germany.
henQ II
- IRR: 30.30%
- Vintage: 2009
- Fund size: €9M
- Close date: October 2009
henQ II is an early-stage VC fund managed by HenQ, a venture capital firm headquartered in Amsterdam. The fund seeks to invest in young technology companies that offer a scalable product and that are managed by strong teams. The fund, which targets international growth markets like new media, mobile and software, has seven former investments, including the Netherlands’ SEOshop Group and CWR Mobility.
More on the private capital markets in France and across Europe
Curious about venture valuations in France?
See our list of French startups with the highest venture valuations
Take a closer look at middle market PE in France
Read our blog post about the top French PE investors by AUM
Ta a closer look at VC in the Netherlands
Read our blog post about the top Dutch VC firms by AUM
See how European PE fared in the second quarter
Download PitchBook’s Q2 2021 European PE Breakdown report
Exploring VC across Europe’s big three
Check out our news coverage on the venture capital landscape in France, the UK and Germany
Credit: Source link
Comments are closed.